These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8233593)
1. Fasciola hepatica: the effect of the microtubule inhibitors colchicine and tubulozole-C on the ultrastructure of the adult fluke. Stitt AW; Fairweather I Parasitology; 1993 Sep; 107 ( Pt 3)():297-309. PubMed ID: 8233593 [TBL] [Abstract][Full Text] [Related]
2. Fasciola hepatica: the effect of the microfilament inhibitor cytochalasin B on the ultrastructure of the adult fluke. Stitt AW; Fairweather I Parasitol Res; 1991; 77(8):675-85. PubMed ID: 1805211 [TBL] [Abstract][Full Text] [Related]
3. Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon. Meaney M; Fairweather I; Brennan GP; Forbes AB Parasitol Res; 2004 Feb; 92(3):232-41. PubMed ID: 14714178 [TBL] [Abstract][Full Text] [Related]
4. The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica. Stitt AW; Fairweather I Parasitology; 1994 Jun; 108 ( Pt 5)():555-67. PubMed ID: 8052511 [TBL] [Abstract][Full Text] [Related]
5. Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica. Meaney M; Haughey S; Brennan GP; Fairweather I Parasitol Res; 2005 Feb; 95(3):201-12. PubMed ID: 15645289 [TBL] [Abstract][Full Text] [Related]
6. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I Parasitology; 2006 Aug; 133(Pt 2):195-208. PubMed ID: 16650337 [TBL] [Abstract][Full Text] [Related]
7. Fasciola hepatica: ultrastructural changes to the tegument of juvenile flukes following incubation in vitro with the deacetylated (amine) metabolite of diamphenethide. Anderson HR; Fairweather I Int J Parasitol; 1995 Mar; 25(3):319-33. PubMed ID: 7601590 [TBL] [Abstract][Full Text] [Related]
8. The effect of the microtubule inhibitor tubulozole-C on the tegument of triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Robinson MW; Trudgett A; Hoey EM; Fairweather I Parasitol Res; 2003 Sep; 91(2):117-29. PubMed ID: 12910417 [TBL] [Abstract][Full Text] [Related]
9. Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax). McKinstry B; Brennan GP; Halferty L; Forbes AB; Fairweather I Parasitol Res; 2007 Sep; 101(4):929-41. PubMed ID: 17557156 [TBL] [Abstract][Full Text] [Related]
10. Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole. Stitt AW; Fairweather I Parasitol Res; 1996; 82(4):333-9. PubMed ID: 8740549 [TBL] [Abstract][Full Text] [Related]
11. Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha. McConville M; Brennan GP; Flanagan A; Edgar HW; McCoy M; Castillo R; Hernández-Campos A; Fairweather I Vet Parasitol; 2008 May; 153(1-2):52-64. PubMed ID: 18359570 [TBL] [Abstract][Full Text] [Related]
12. The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver fluke Fasciola hepatica. Skuce PJ; Fairweather I Parasitol Res; 1990; 76(3):241-50. PubMed ID: 2315284 [TBL] [Abstract][Full Text] [Related]
13. Fasciola hepatica: perturbation of secretory activity in the vitelline cells by the sodium ionophore monensin. Skuce PJ; Fairweather I Exp Parasitol; 1988 Feb; 65(1):20-30. PubMed ID: 3338546 [TBL] [Abstract][Full Text] [Related]
14. Fasciola hepatica: the effect of the sodium ionophore monensin on the adult tegument. Skuce PJ; Fairweather I Parasitol Res; 1989; 75(3):223-32. PubMed ID: 2540490 [TBL] [Abstract][Full Text] [Related]
15. Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen'). Buchanan JF; Fairweather I; Brenna GP; Trudgett A; Hoey EM Parasitology; 2003 Feb; 126(Pt 2):141-53. PubMed ID: 12636352 [TBL] [Abstract][Full Text] [Related]
16. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host. Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I Vet Parasitol; 2010 Dec; 174(3-4):218-27. PubMed ID: 20933333 [TBL] [Abstract][Full Text] [Related]
17. Ultrastructural changes in the tegument and gut of adult Fasciola hepatica following in vivo treatment with artesunate. O'Neill JF; Johnston RC; Halferty L; Brennan GP; Fairweather I Exp Parasitol; 2015 Jul; 154():143-54. PubMed ID: 25917645 [TBL] [Abstract][Full Text] [Related]
18. Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica. Halferty L; O'Neill JF; Brennan GP; Keiser J; Fairweather I Parasitology; 2009 Sep; 136(11):1325-37. PubMed ID: 19660154 [TBL] [Abstract][Full Text] [Related]
19. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil. Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567 [TBL] [Abstract][Full Text] [Related]
20. Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model. O'Neill JF; Johnston RC; Halferty L; Brennan GP; Keiser J; Fairweather I J Helminthol; 2009 Jun; 83(2):151-63. PubMed ID: 19368748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]